Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 LGM Pharma Receives Majority Investment | Contract Pharma

What are you searching for?

Sign in
Breaking News

LGM Pharma Receives Majority Investment

The equity group has over $400 million capital under management, and focuses on growth-oriented healthcare

By: Betsy Louda

, Contract Pharma

New Harbor Capital has completed a majority equity investment in LGM Pharma, a company involved in distribution of cGMP active pharmaceutical ingredients (“API”) and other value-added services supporting leading pharmaceutical companies. 

 

“New Harbor’s strong track record of successfully executing growth strategies, as well as their experience with the healthcare industry and pharmaceutical services, will elevate our business to the next level while upholding the high quality, innovation and reliable service our customers expect,” said Gideon Schurder, commercial director at LGM Pharma.
 

“We welcome LGM to our growing healthcare portfolio,” said Jocelyn Stanley, principal at New Harbor Capital. “We are excited to partner with LGM’s co-founders Mendy and Gideon Schurder to support efforts to strategically grow the business.” 

 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics